The Trump admin just filed a brief that continues to defend FDA's regulation of medication abortion before a judge in Texas. As I wrote on Friday for Health Affairs, this is not too surprising, esp given the weakness of the states' arguments. litigationtracker.law.georgetown.edu/wp-content/u...

ICYMI: The Trump admin is facing a big test on medication abortion, and the stakes could not be higher. New federal restrictions from the courts or the Trump admin would dramatically reduce abortion access in states where abortion is legal and compromise reproductive health care.

Watch what happens this Monday, when the Trump DOJ has to file a brief in the Mifepristone case pending before Judge Kacsmaryk. Katie Keith has a great write-up here describing the case and setting forth the range of actions the Trump Administration might take. www.healthaffairs.org/content/fore...

Well, that didn't take long: HHS is working on a new proposed rule on the Affordable Care Act. This is currently the *only* HHS action pending at OMB. Just as it did in 2017, the Trump administration looks to be moving quickly on ACA marketplace policies. www.reginfo.gov/public/do/eo...

Always read @katie-keith.bsky.social, who's back analyzing current developments in health law and policy for Health Affairs Forefront. First up: her look ahead at key events to watch for in 2025, including executive actions, litigation, and legislation. www.healthaffairs.org/content/fore...

Health Policy At A Crossroads: What To Watch In 2025 | Health Affairs Forefront

This article does not attempt to predict the potential policies that the new administration and Congress might pursue or how they will set priorities. Instead, this article discusses the various near-...

healthaffairs.org